Anemia after renal transplantation: an underestimated problem

Area of Science:

• Nephrology
• Transplantation Immunology
• Hematology

Background:

• Anemia is a known risk factor for cardiovascular disease and mortality in end-stage renal disease patients.
• Renal transplantation is a treatment option for end-stage renal disease, but post-transplant complications require investigation.

Purpose of the Study:

• To investigate the incidence and predictors of anemia in stable renal transplant recipients.
• To assess the impact of anemia on mortality and graft failure rates in the post-transplant period.

Main Methods:

• Retrospective analysis of 207 stable patients undergoing first renal transplantation.
• Data collection on patient demographics, immunosuppressive therapy, hemoglobin levels, and serum creatinine.
• Follow-up for 3 years to record mortality and graft failure events.

Main Results:

• Anemia was present in 37.7% of patients, with varying severity.
• Higher serum creatinine levels (>200 micromol/L) significantly predicted anemia.
• Anemic patients had significantly greater 3-year mortality (3.3% vs 0.5%) and graft failure rates (4.3% vs 0%) compared to non-anemic patients.

Conclusions:

• Anemia is highly prevalent in renal transplant recipients, even with well-functioning grafts.
• Anemia is an independent risk factor for increased mortality and graft failure post-renal transplantation.
• More intensive treatment strategies for anemia are warranted in renal transplant patients to improve long-term outcomes.